Bilera honen helburu nagusia SARS-CoV-2 eta COVID-19 azterlanei buruzko gaur egungo ezagutzak eta etorkizuneko orientabideak eguneratzea da.

Webinarrera sartzea doakoa da.

Izen ematea hemen.

PROGRAMA

17:00     Welcome and introductory remarks

Jesús M. Bañales.IIS Biodonostia. San Sebastián, Spain.
Manuel Romero-Gómez. Virgen del Rocío University Hospital. Seville, Spain
Ángeles Pérez Aisa. President of the Andalusian Society of Digestive Pathology

17:05     Role of Host Genetics in COVID-19 severity

Mª Tom Karlsen.. Oslo University Hospital. Oslo, Norway.

17:20     Role of the ABO blood group in SARS-CoV-2 infection and disease

Andre Franke. Institut für Klinische Molekularbiologie. Kiel, Germany.

17:35     Which is the hominin ancestor carrying risk variant haplotypes?

Luca Valenti. University of Milan. Milan, Italy.

17:50     Sequencing SARS-CoV-2 as an opportunity

Federico García. San Cecilio Clinic Hospital. Granada, Spain.

18:05     Personalized and Precision Medicine in COVID-19

Manuel Romero-Gómez.Virgen del Rocío University Hospital. Seville, Spain.

18:20     Panel discussion

Chairman: Jesús M. Bañales.IIS Biodonostia. San Sebastian, Spain.

Agustín Albillos.Ramón y Cajal University Hospital. Madrid, Spain.
Luis Bujanda.IIS Biodonostia. San Sebastián, Spain.
María Buti.Vall d’Hebron Hospital. Barcelona, Spain.
Javier Fernández.Clinic University Hospital. Barcelona, Spain.

18:50      Innovation Research in the management of the pandemic

Isaac Túnez.Secretary General for Research, Development and Innovation. Ministry of Health and Family. Andalusia Regional Government. Spain.

19:00        Concluding remarks